Physician profile
Shannon Brindle
NPI 1659799120
$4,009.11
in general payments reported to CMS, 2019-2025
12 companies · $2,503 in 2025
The $2,503 reported for 2025 was more than what 81% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $499 · 2023: $380 · 2024: $627 · 2025: $2,503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,843 · Food and Beverage: $1,666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,843.29 |
| Food and Beverage | $1,666.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,843.29 | 2025 | |
| Smith+Nephew, INC. | $645.69 | 2023-2025 | Renasys Touch, Stravix Pl, Grafix Pl |
| Zimmer Biomet Holdings, INC. | $338.70 | 2022 | |
| Boston Scientific Corporation | $262.55 | 2024-2025 | Spyglass Discover |
| Stryker Corporation | $170.17 | 2025 | 1788 |
| Medtronic, INC. | $161.19 | 2024 | Sonicision, Dextile |
| Teleflex LLC | $135.68 | 2025 | Arrow, Quikclot |
| Takeda Pharmaceuticals U.S.A., INC. | $124.74 | 2022 | |
| Haemonetics Corporation | $120.76 | 2024 | Teg6s Hemostasis System |
| Solventum Corporation | $96.75 | 2025 | V.A.C. Veraflo, Abthera |
| Atricure, INC. | $91.49 | 2022-2023 | |
| Integra Lifesciences Corporation | $18.10 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Brindle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.